INZY | Inozyme Pharma, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.5700 - 2.8499
52 Week Range	2.5500 - 7.80
Beta	1.08
Implied Volatility	424.27%
IV Rank	31.43%
Day's Volume	444,076
Average Volume	355,528
Shares Outstanding	64,240,200
Market Cap	170,878,932
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-07-24

Valuation
Profitability
Growth
Health
P/E Ratio	-1.72
Forward P/E Ratio	N/A
EPS	-1.55
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	59
Country	USA
Website	INZY

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

INZY's peers: ABEO, ABOS, ABSI, ACHV, AFMD, AKRO, ALDX, ALT, ALZN, AMLX, ANNX, ANVS, APLS, ARDX, ARQT, AUTL, BBIO, BCLI, BCTX, BHVN, BIVI, BLRX, BPMC, BTAI, CLSD, CNTX, CPRX, CRBP, CRIS, CRVS, CTXR, CYTK, DAWN, DTIL, ELDN, ETNB, EYEN, GLSI, GOSS, HOOK, HRMY, HRTX, IDYA, IFRX, INKT, INVA, XFOR, MREO, TERN, PDSB, DRTS, JSPR, KURA, LPTX, LQDA, MDGL, MDXG, MDXH, MEIP, MESO, MGNX, MIRM, MRNS, MRSN, NCNA, NERV, OCUL, ORMP, OTLK, PGEN, PHAT, PIRS, PLRX, PRTG, PYXS, QURE, RARE, RCKT, RCUS, RIGL, ROIV, RXRX, RYTM, SLNO, SNDX, SPRB, TCRX, TNYA, TSHA, TSVT, VIRX, VKTX, VRDN, VRNA, VYGR, WVE, XBIT, XERS, ZNTL, ZYME, ERNA, COYA, GPCR

*Chart delayed

Analyzing fundamentals for INZY we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see INZY Fundamentals page.

Watching at INZY technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INZY Technicals page.